These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10800764)

  • 1. From macroprolactinoma to concomitant ACTH-PRL hypersecretion with Cushing's disease.
    Barausse M; Attanasio R; Dallabonzana D; Oppizzi G; Veronese S; Lasio G; Valentini LG; Cozzi R
    J Endocrinol Invest; 2000 Feb; 23(2):107-11. PubMed ID: 10800764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macroprolactinoma associated with Cushing's disease, successfully treated with cabergoline.
    T'Sjoen G; Defeyter I; Van De Saffele J; Rubens R; Vandeweghe M
    J Endocrinol Invest; 2002 Feb; 25(2):172-5. PubMed ID: 11929090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apparently complete restoration of normal daily adrenocorticotropin, cortisol, growth hormone, and prolactin secretory dynamics in adults with Cushing's disease after clinically successful transsphenoidal adenomectomy.
    Veldman RG; Frölich M; Pincus SM; Veldhuis JD; Roelfsema F
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4039-46. PubMed ID: 11095430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cushing's disease and hyperprolactinemia due to a mixed ACTH- and prolactin-secreting pituitary macroadenoma.
    Mahler C; Verhelst J; Klaes R; Trouillas J
    Pathol Res Pract; 1991 Jun; 187(5):598-602. PubMed ID: 1656408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concomitant Cushing's Disease and Marked Hyperprolactinemia: Response to a Dopamine Receptor Agonist.
    Shiraishi J; Koyama H; Shirakawa M; Ishikura R; Okazaki H; Kurajoh M; Shoji T; Moriwaki Y; Yamamoto T; Namba M
    Intern Med; 2016; 55(8):935-41. PubMed ID: 27086808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acromegaly with hyperprolactinemia developed after bilateral adrenalectomy in a patient with Cushing's syndrome due to adrenocortical nodular hyperplasia.
    Ogo A; Haji M; Natori S; Kanzaki T; Kabayama Y; Osamura RY; Nawata H; Ibayashi H
    Endocr J; 1993 Feb; 40(1):17-25. PubMed ID: 7951491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of inferior petrosal sinus venous endocrine markers in Cushing's disease.
    Zovickian J; Oldfield EH; Doppman JL; Cutler GB; Loriaux DL
    J Neurosurg; 1988 Feb; 68(2):205-10. PubMed ID: 2828570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperprolactinemia in Cushing's disease and Nelson's syndrome.
    Yamaji T; Ishibashi M; Teramoto A; Fukushima T
    J Clin Endocrinol Metab; 1984 May; 58(5):790-5. PubMed ID: 6323516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cushing's disease and marked hyperprolactinemia in a patient with a pituitary macroadenoma: effectiveness of bromocriptine treatment.
    Verde G; Loli P; Berselli ME; Tagliaferri M; Dallabonzana D; Oppizzi G; Liuzzi A; Chiodini PG; Luccarelli G; Lodrini S
    J Endocrinol Invest; 1984 Feb; 7(1):51-4. PubMed ID: 6715796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-step development of a pituitary adenoma: from hyperprolactinemic syndrome to Cushing's disease.
    Gheri RG; Boddi W; Ammannati F; Olivotto J; Nozzoli C; Franchi A; Bordi L; Luisi ML; Mennonna P
    J Endocrinol Invest; 1997 Apr; 20(4):240-4. PubMed ID: 9211134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Multihormonal bilateral petrosal sinus sampling in Cushing's disease: radiological, surgical and pathological correlations].
    Valdes Socin H; Bataille Y; Meurisse N; Flandroy P; Stevenaert A; Beckers A
    Ann Endocrinol (Paris); 2002 Feb; 63(1):23-30. PubMed ID: 11937979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of prolactin secretion in patients with Cushing's disease. A comparative study on the effects of dexamethasone, lysine vasopressin and ACTH on prolactin secretion by the rat pituitary gland in vitro.
    Lamberts SW; de Quijada M; Visser TJ
    Neuroendocrinology; 1981 Mar; 32(3):150-4. PubMed ID: 6261178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coexisting corticotroph and lactotroph adenomas: case report with reference to the relationship of corticotropin and prolactin excess.
    Wynne AG; Scheithauer BW; Young WF; Kovacs K; Ebersold MJ; Horvath E
    Neurosurgery; 1992 Jun; 30(6):919-23. PubMed ID: 1319562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double pituitary lesions in three patients with Cushing's disease.
    Meij BP; Lopes MB; Vance ML; Thorner MO; Laws ER
    Pituitary; 2000 Nov; 3(3):159-68. PubMed ID: 11383480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas.
    Katznelson L; Bogan JS; Trob JR; Schoenfeld DA; Hedley-Whyte ET; Hsu DW; Zervas NT; Swearingen B; Sleeper M; Klibanski A
    J Clin Endocrinol Metab; 1998 May; 83(5):1619-23. PubMed ID: 9589666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocrinological outcome following first time transsphenoidal surgery for GH-, ACTH-, and PRL-secreting pituitary adenomas.
    Kristof RA; Schramm J; Redel L; Neuloh G; Wichers M; Klingmüller D
    Acta Neurochir (Wien); 2002 Jun; 144(6):555-61; discussion 561. PubMed ID: 12111488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cavernous sinus sampling is highly accurate in distinguishing Cushing's disease from the ectopic adrenocorticotropin syndrome and in predicting intrapituitary tumor location.
    Graham KE; Samuels MH; Nesbit GM; Cook DM; O'Neill OR; Barnwell SL; Loriaux DL
    J Clin Endocrinol Metab; 1999 May; 84(5):1602-10. PubMed ID: 10323387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
    Mukherjee A; Murray RD; Teasdale GM; Shalet SM
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of postoperative ACTH levels as a marker for successful transsphenoidal microsurgery in Cushing's disease.
    Flitsch J; Knappe UJ; Lüdecke DK
    Zentralbl Neurochir; 2003; 64(1):6-11. PubMed ID: 12582940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a met-enkephalin analog on adrenocorticotropin (ACTH), growth hormone, and prolactin in patients with ACTH hypersecretion.
    Allolio B; Winkelmann W; Hipp FX; Kaulen D; Mies R
    J Clin Endocrinol Metab; 1982 Jul; 55(1):1-7. PubMed ID: 6281297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.